Use of the inhibitors of sodium-glucose cotransporter 2 in patients with different heart failure phenotypes and with type 2 diabetes mellitus

• Applicant: Dr. Peter Moritz Becher
• Subject Area: Cardiology, Angiology
• Term: from 2021 to 2022
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 456458270

• Final Report Year: 2022

No abstract available

Publications

• Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry. European Journal of Heart Failure, 23(11), 1844-1854.
  Becher, Peter Moritz; Schrage, Benedikt; Benson, Lina; Fudim, Marat; Corovic, Cabrera Carin; Dahlström, Ulf; Rosano, Giuseppe M.C.; Jankowska, Ewa A.; Anker, Stefan D.; Lund, Lars H. & Savarese, Gianluigi
  
• Use of sodium–glucose co‐transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry. European Journal of Heart Failure, 23(6), 1012-1022.
  Becher, Peter M.; Schrage, Benedikt; Ferrannini, Giulia; Benson, Lina; Butler, Javed; Carrero, Juan Jesus; Cosentino, Francesco; Dahlström, Ulf; Mellbin, Linda; Rosano, Giuseppe M.C.; Sinagra, Gianfranco; Stolfo, Davide; Lund, Lars H. & Savarese, Gianluigi
  
• Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular Research, 118(17), 3272-3287.
  Savarese, Gianluigi; Becher, Peter Moritz; Lund, Lars H.; Seferovic, Petar; Rosano, Giuseppe M. C. & Coats, Andrew J. S.